Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Twin study identifies the influence of environment and genetics in multiple sclerosis

Researchers at the University of Zurich and Munich's LMU Klinikum hospital have studied the immune system of pairs of monozygotic twins to identify the influence of the environment and of genetics in cases of multiple sclerosis.

16 Feb 2022

Induction and stability of vaccine-specific antibodies in multiple sclerosis patients on different disease-modifying therapies

Researchers have investigated the lack of response to treatment in certain multiple sclerosis patients.

9 Feb 2022

Using sugar molecules for in vivo tracking of unlabeled stem cells

A Johns Hopkins Medicine scientist who spent 30 years figuring out how to put chemical labels into cells to track their movement in living tissues has found that certain self-renewing stem cells have built-in tracers -; made out of sugars -; that can do the job without added chemical "labels" when injected into mouse brains.

8 Feb 2022

Researchers investigate how discontinuing the multiple sclerosis drug affects expectant mothers

MS relapses of clinical relevance are known to occur in up to 80 per cent of patients within four to seven months of stopping natalizumab. It is also a known fact that pregnancy has a mitigating effect on the disease.

4 Feb 2022

New toolkit helps practitioners to deliver effective remote assessments for people with physical impairments

Appointments for people with physical impairments were quickly made remote during the pandemic – with a lack of consistency or guidance around what could take place remotely and what would need to wait for an in-person visit.

31 Jan 2022

Oligodendrocytes may have a different role in the development of multiple sclerosis, study finds

An international team of researchers led by Karolinska Institutet in Sweden have discovered that a cell type in the central nervous system known as oligodendrocytes might have a different role in the development of multiple sclerosis (MS) than previously thought.

28 Jan 2022

Desipramine and L-cycloserine together reduce ceramide levels in the retina and enhance vision

Researchers from the University of California, Irvine have discovered that the absence of Adiponectin receptor 1 protein (AdipoR1), one of the principal enzymes regulating ceramide homeostasis in the retina, leads to an accumulation of ceramides in the retina, resulting in progressive photoreceptor cell death and ultimately vision loss.

28 Jan 2022

Research teases out connection between diet, immune response, gut bacteria and multiple sclerosis

Eating more meat, having less of certain bacteria in the gut, and more of certain immune cells in the blood, all link with multiple sclerosis, reports a team of researchers led by UConn Health and Washington University School of Medicine.

27 Jan 2022

ANU researchers identify why Th17 cells go rogue and promote the onset of multiple sclerosis

Researchers from The Australian National University (ANU) have identified why certain cells in the body, known as Th17 cells, go rogue and promote the onset of autoimmune diseases such as multiple sclerosis (MS).

27 Jan 2022

Novel robotic replica of human spine enables surgeons to preview the effects of surgery

Degenerative disc disease affects about 40 percent of people aged 40, increasing to about 80 percent among those aged 80 or older. The disease, which is the deterioration of one or more intervertebral discs of the spine, often is surgically treated with cervical disc implants.

19 Jan 2022

New MRI technique could pave the way to quicker assessment of multiple sclerosis

It is important that multiple sclerosis (MS) is diagnosed and treated as early as possible in order to delay progression of the disease.

18 Jan 2022

Multiple sclerosis may be caused by infection with the Epstein-Barr virus

Multiple sclerosis (MS), a progressive disease that affects 2.8 million people worldwide and for which there is no definitive cure, is likely caused by infection with the Epstein-Barr virus (EBV), according to a study led by Harvard T.H. Chan School of Public Health researchers.

13 Jan 2022

Cellular and humoral response to SARS-CoV-2 in multiple sclerosis patients using disease-modifying therapies

Researchers examine the effects of disease-modifying therapies implemented for treating multiple sclerosis on the immune response to SARS-CoV-2 infection.

12 Jan 2022

New type of blood test can be used to detect cancers as well as metastatic disease

A publication by University of Oxford researchers describes a new minimally invasive and inexpensive blood test that can identify cancer in patients with non-specific symptoms.

12 Jan 2022

Biosimilars could drive down drug prices and lead to $38.4 billion savings

Biosimilar drugs could drive down prices for expensive medicines used to treat illnesses such as cancer and rheumatoid arthritis, with savings estimated to be $38.4 billion or 5.9% of projected total U.S. spending on biologics from 2021 to 2025, according to a new RAND Corporation study.

10 Jan 2022

Moderna announces initiation of Phase 1 study of its mRNA-1189 EBV vaccine candidate

Moderna, Inc., a biotechnology company pioneering messenger RNA therapeutics and vaccines, today announced the first participant has been dosed in the Phase 1 study of mRNA-1189, the Company's Epstein-Barr Virus vaccine candidate.

7 Jan 2022

Study reinforces the link between microglia and some cases of brain disease

Certain subtle differences in DNA sequences are known to raise the chances a person may develop Alzheimer's or Parkinson's disease.

6 Jan 2022

New study links anxiety and PTSD to increased myelin in brain's gray matter

A recent study links anxiety behavior in rats, as well as post traumatic stress disorder (PTSD) in military veterans, to increased myelin - a substance that expedites communication between neurons - in areas of the brain associated with emotions and memory.

6 Jan 2022

As covid hits nursing homes’ finances, town residents fight to save Alzheimer’s facility

Marvin Querry, 86, was on his tractor, planting rye on his 770-acre western Missouri farm, when the call came in early November.

4 Jan 2022

Promoting exercise as basic need for managing the physical and cognitive symptoms of MS

Citing recent evidence, experts in rehabilitation research advocate for integrating exercise into the care plans of persons with multiple sclerosis. The central role of the neurologist in clinical care offers an opportunity for this provider to promote exercise as fundamental for managing the physical and cognitive symptoms of MS.

30 Dec 2021

Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Twin study identifies the influence of environment and genetics in multiple sclerosis

Induction and stability of vaccine-specific antibodies in multiple sclerosis patients on different disease-modifying therapies

Using sugar molecules for in vivo tracking of unlabeled stem cells

Researchers investigate how discontinuing the multiple sclerosis drug affects expectant mothers

New toolkit helps practitioners to deliver effective remote assessments for people with physical impairments

Oligodendrocytes may have a different role in the development of multiple sclerosis, study finds

Desipramine and L-cycloserine together reduce ceramide levels in the retina and enhance vision

Research teases out connection between diet, immune response, gut bacteria and multiple sclerosis

ANU researchers identify why Th17 cells go rogue and promote the onset of multiple sclerosis

Novel robotic replica of human spine enables surgeons to preview the effects of surgery

New MRI technique could pave the way to quicker assessment of multiple sclerosis

Multiple sclerosis may be caused by infection with the Epstein-Barr virus

Cellular and humoral response to SARS-CoV-2 in multiple sclerosis patients using disease-modifying therapies

New type of blood test can be used to detect cancers as well as metastatic disease

Biosimilars could drive down drug prices and lead to $38.4 billion savings

Moderna announces initiation of Phase 1 study of its mRNA-1189 EBV vaccine candidate

Study reinforces the link between microglia and some cases of brain disease

New study links anxiety and PTSD to increased myelin in brain's gray matter

As covid hits nursing homes’ finances, town residents fight to save Alzheimer’s facility

Promoting exercise as basic need for managing the physical and cognitive symptoms of MS

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in